96,189 Shares in Cannae Holdings, Inc. $CNNE Purchased by Palogic Value Management L.P.

Palogic Value Management L.P. acquired a new position in Cannae Holdings, Inc. (NYSE:CNNE) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 96,189 shares of the company’s stock, valued at approximately $1,385,000. Palogic Value Management L.P. owned 0.22% of Cannae as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Cannae by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,465 shares of the company’s stock worth $613,000 after purchasing an additional 1,405 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Cannae by 4.1% in the first quarter. Goldman Sachs Group Inc. now owns 299,843 shares of the company’s stock valued at $5,496,000 after purchasing an additional 11,788 shares during the last quarter. Jane Street Group LLC grew its holdings in Cannae by 95.4% during the first quarter. Jane Street Group LLC now owns 54,393 shares of the company’s stock valued at $997,000 after purchasing an additional 26,550 shares during the period. Quantbot Technologies LP bought a new position in Cannae during the second quarter valued at $62,000. Finally, Jump Financial LLC increased its position in Cannae by 353.3% in the second quarter. Jump Financial LLC now owns 64,606 shares of the company’s stock worth $1,347,000 after buying an additional 50,353 shares during the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Cannae Stock Performance

Shares of CNNE stock opened at $15.40 on Thursday. Cannae Holdings, Inc. has a 12 month low of $10.46 and a 12 month high of $19.88. The stock has a market capitalization of $667.96 million, a P/E ratio of -5.10 and a beta of 1.20. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.07. The firm’s 50 day moving average is $14.72 and its 200 day moving average is $13.58.

Cannae (NYSE:CNNE) last issued its earnings results on Monday, August 10th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.42) by $1.28. Cannae had a negative net margin of 38.18% and a negative return on equity of 14.10%. The business had revenue of $102.20 million for the quarter, compared to analysts’ expectations of $99.65 million.

Cannae Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date is Wednesday, September 16th. Cannae’s payout ratio is presently -19.87%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CNNE. Royal Bank Of Canada restated an “outperform” rating and issued a $16.00 target price on shares of Cannae in a research note on Tuesday, August 11th. Wall Street Zen raised Cannae from a “sell” rating to a “hold” rating in a report on Saturday, August 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Cannae in a report on Monday, July 6th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $16.50.

Cannae Profile

Cannae Holdings, Inc (NYSE: CNNE) is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae’s investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.

Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.